Similar Papers

Paper Title
Journal
Date
Author
Management of Intestinal Complications in Patients With Pelvic Radiation Disease
Lorenzo Fuccio ... H Jervoise N Andreyev
Clinical Gastroenterology and Hepatology | VOL. 10
Lorenzo Fuccio, et. al.Lorenzo Fuccio ... H Jervoise N Andreyev
30 Jul 2012
PEARLS: Is Our Use of Prostate-specific Membrane Antigen Positron Emission Tomography-Computed Tomography Meaningful for Our Patients?
J.R Murray ... E Hall
Clinical Oncology | VOL. 34
J.R Murray, et. al.J.R Murray ... E Hall
29 May 2022
Ultrahypofractionation Should be a Standard of Care Option for Intermediate-Risk Prostate Cancer
A Loblaw
Clinical Oncology | VOL. 32
A LoblawA Loblaw
28 Nov 2019
The role of hormone therapy as a neoadjuvant to radical prostate radiotherapy.
C Parker ... D Dearnaley
Clinical oncology (Royal College of Radiologists (Great Britain)) | VOL. 15
C Parker, et. al.C Parker ... D Dearnaley
01 Sep 2003
View more papers

More From: International Journal of Radiation Oncology*Biology*Physics

Paper Title
Journal
Date
Author
Erratum to: Gondi V, Deshmukh S, Brown PD, et al. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001. Int J Radiat Oncol Biol Phys. 2023;117:571-580.
Vinai Gondi ... Lisa A Kachnic
International Journal of Radiation Oncology*Biology*Physics | VOL. 121
Vinai Gondi, et. al.Vinai Gondi ... Lisa A Kachnic
01 Feb 2025
Issue Highlights
-
International Journal of Radiation Oncology*Biology*Physics | VOL. 121
--
01 Feb 2025
Issue Highlights
-
International Journal of Radiation Oncology*Biology*Physics | VOL. -
--
01 Jan 2025
Combined molecular subclass and immune phenotype correlate to atezolizumab plus radiation therapy response in invasive bladder cancer: BPT-ART Phase II study
Yoshiyuki Nagumo ... Hiroyuki Nishiyama
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Yoshiyuki Nagumo, et. al.Yoshiyuki Nagumo ... Hiroyuki Nishiyama
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.